CL Biologics

Launched in 2020, CL Biologics (CLB) is a premier biologics contract development and manufacturing organization (CDMO). Led by an experienced international team, CLB offers comprehensive CDMO services featuring: • World-Class Facilities: State-of-the-art infrastructure • Robust Process Design: Efficient and innovative • Digital Quality Systems: Advanced and precise • Global Compliance: Adherence to cGMP and international regulations Currently, CLB is constructing advanced CDMO plants in Shenzhen and Shanghai, targeting over 700kL capacity by 2026. CLB is committed to innovation, quality, and enhancing global healthcare outcomes. Mission: Enabling High Quality, Affordable Biologics Worldwide